Singapore markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
27.84+0.30 (+1.07%)
As of 03:09PM EST. Market open.

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO11.72MN/A1962
Mr. David M. DentonChief Financial Officer & Executive VP18.19MN/A1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development5.82MN/A1958
Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting OfficerN/AN/A1968
Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology OfficerN/AN/A1969
Ms. Francesca M. DeMartinoChief Investor Relations OfficerN/AN/AN/A
Mr. Douglas M. LanklerExecutive VP & General Counsel3.78M1.85M1966
Mr. Rady A. JohnsonExecutive VP and Chief Compliance, Quality & Risk OfficerN/AN/A1962
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerN/AN/AN/A
Ms. Payal Sahni BecherChief People Experience Officer & Executive VPN/AN/A1975
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate governance

Pfizer Inc.’s ISS governance QualityScore as of 1 February 2024 is 5. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.